Hey Tony, I agree but it’s hard not to be appear a little negative at the moment with the company coming across so secretive over a simple ethics lodgement. Where is the delay? Today is the 12th November with no ethics submission in sight.
I’m as bullish as I can be at the moment but I’m operating on a once bitten twice shy stance until I see the company meet a very valuable inflection point (dosing).
I can’t help but be a little frustrated by the hardest working asx bio tech team when we've had no news of significance since the Hoff joined. The rebate news was welcome too I guess. Hope something decent transpires pre AGM otherwise what’s there to discuss?
Just my thoughts for today I can sympathise with those having an opposing view lately because some days it feels like we’re back on the merry go round of Deja Vu..
Add to My Watchlist
What is My Watchlist?
